Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.03 Insider Own64.90% Shs Outstand13.39M Perf Week6.77%
Market Cap4.16M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.70M Perf Month-52.20%
Income1.52M PEG- EPS next Q- Inst Own15.24% Short Float8.06% Perf Quarter-62.75%
Sales0.00M P/S- EPS this Y- Inst Trans14.79% Short Ratio0.82 Perf Half Y-96.98%
Book/sh-0.40 P/B- EPS next Y- ROA1.13% Short Interest0.38M Perf Year-96.93%
Cash/sh0.01 P/C46.23 EPS next 5Y- ROE1.27% 52W Range0.27 - 14.55 Perf YTD-96.64%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-97.86% Beta-0.34
Dividend TTM- Quick Ratio0.01 Sales past 5Y- Gross Margin- 52W Low16.54% ATR (14)0.05
Dividend Ex-Date- Current Ratio0.01 EPS Y/Y TTM-105.54% Oper. Margin0.00% RSI (14)25.74 Volatility9.65% 12.24%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-413.01% Payout- Rel Volume0.28 Prev Close0.33
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume460.97K Price0.31
SMA20-24.69% SMA50-55.19% SMA200-93.77% Trades Volume130,974 Change-5.76%
Jul-03-24 08:34PM
Jun-21-24 07:52AM
May-17-24 07:00AM
Apr-17-24 08:00AM
Apr-16-24 11:01AM
11:01AM Loading…
Apr-08-24 08:00AM
Mar-26-24 11:06AM
Mar-18-24 04:05PM
Mar-15-24 04:30PM
Mar-12-24 11:15AM
Mar-11-24 07:00AM
03:59PM Loading…
Mar-08-24 03:59PM
Mar-06-24 07:00AM
Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.